Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation.

Christelle Ferra Coll Mireia Morgades Laura Prieto García Carlos Pinho Vaz María Inmaculada Heras Fernando Rebeca Bailen Almorox García-Cadenas Irene Marisa Calabuig Teresa Zudaire Ripa Joud Zanabilli Sandra Novoa Beatriz Aguado Bueno Anna Torrent Catarineu Oriana Lopez-Godino Rodrigo Martino Bofarull Mi Kwon Antonio Campos Júnior Dolores Caballero Barrigón Josep-María Ribera

Published in: European journal of haematology (2023)

Despite the poor prognosis of patients with ALL presenting relapse after a first allo-SCT, some can be satisfactorily rescued and a second allo-SCT still remains a valid option for selected patients. Moreover, emerging therapies really might improve ALL patients outcome when relapsing after an allo-SCT.

Keyphrases

stem cell transplantation
poor prognosis
end stage renal disease
multiple sclerosis
ejection fraction
newly diagnosed
chronic kidney disease
long non coding rna
bone marrow
low dose
systemic lupus erythematosus
disease activity
patient reported outcomes
case report